Cancer education made simple # Chandrakanth MV
Cancer education made simple # Chandrakanth MV
  • 64
  • 17 322
Adjuvant CDK 4/6 Breast cancer #Abemaciclib-MonarchE or RIbociclib-NATALEE#Debate
Join us for an exciting debate on adjuvant CDK 4/6 trials! We explore why Abemaciclib might be the best choice. Both drugs can save lives and change how we practice medicine. It’s dramatic, fun, and full of surprising facts. Don’t miss it!
Переглядів: 76

Відео

Key note 522 Simplified# Pembrolizumab in TNBC #Early Breast Cancer# immunotherapy
Переглядів 10014 днів тому
All you want to know about key note 522 .A simplified video covering almost all details.
Belzutifan #5 unique points# Welireg #Lite spark 005# kidney cancer # Clear cell RCC
Переглядів 6421 день тому
All you want to know about Belzutifan Lite spark 005
IM passion#Guess the molecule#Oncology meme
Переглядів 89Місяць тому
This short video explains how a molecule is approved and revised over time. It covers not only single randomized trials but also other evidence that exists and evolves over time.
Mastering Internal Assessment in DNB Exams #Ten Must Know facts#By Chandrakanth MV
Переглядів 583 місяці тому
Discover the essential guidelines for internal assessment in DNB exams as outlined by NBEMS. This video highlights the ten must-know things that are beneficial for both trainees and faculty members. Gain valuable insights to excel in your DNB exams by watching now!
HIPEC #Ovarian Cancer#Success story#Debate#Best and Economic treatment #Stage 3/4 ovarian cancer
Переглядів 4910 місяців тому
Short clip on debating for the motion for HIPEC in advanced ovarian cancer
Mouth Cancer #Best Treatment# Response and Survival#Indian Study from Bengal#cetuximab f/b Nivolumab
Переглядів 9610 місяців тому
Short video on using the most user friendly regimen for oral cavity cancer #Paclitaxel carboplatin cetuximab followed bhy Nivolumab
Relapsed ALL/Acute Lymphoblastic Leukemia /Inotuzumab Ozogomycin#CAR-T/Inovate Trial#Critical review
Переглядів 176Рік тому
Shortcomings of Inotuzumab Ozogomycin /Risks benefit Ratio/Dissection of the Inovate trial/Critical analysis
Adjuvant Abemaciclib/Ribociclib #monarchE/NATALEE #Best Treatment for Breast cancer #CDK 4/6 -Cure
Переглядів 623Рік тому
Rationale for using Adjuvant CDK 4/6 inhibitor in HR /Her 2 Negative Breast Cancer
Low dose immunotherapy #Nivolumab# cancer #is it right# The Untold story # reduce cost #Debate
Переглядів 339Рік тому
I will provide the rationality and scientific basis for low dose immunotherapy .There are preclinical ,Phase 1 , 2 and Phase 3 data to use low dose immunotherapy .How we can deliver immunotherapy at lesser cost maintaining the efficacy
salivary gland cancers#Adenoid cystic carcinoma#Androgen receptor#Novel Treatment#Abiraterone#ATRA
Переглядів 3732 роки тому
We will answer the following questions How I treat salivary gland cancers with Androgen Receptor expression? How to treat Adenoid cystic carcinoma ?
All you want to know about DOSTARLIMAB # 100 % cure for cancer -is it true
Переглядів 3,2 тис.2 роки тому
Dostarlimab has shown 100% complete response in dMMR rectal cancers .We will have a close look into the data
5 Flurouracil / capecitabine cardiotoxicity # cancer drugs and heart #Heart failure and cancer
Переглядів 6262 роки тому
5FU -most commonly chemotherapy drug is associated with 8% incidence of coronary event.This video tells you everything about it-How to diagnose,How to manage and How to modify further anticancer therapy
visceral crisis, Breast cancer
Переглядів 5492 роки тому
Short Review -Dr Chandrakanth MV
IAPEN 2022 oncology guidelines
Переглядів 2112 роки тому
Quick and simplified review Presenter -Dr Chandrakanth MV
Ideal Diet for Cancer Patients
Переглядів 1,5 тис.3 роки тому
Ideal Diet for Cancer Patients
Sath Sath Session 4 (Aug 2021)
Переглядів 1403 роки тому
Sath Sath Session 4 (Aug 2021)
Sath Sath Session 3 (Jul 2021)
Переглядів 1083 роки тому
Sath Sath Session 3 (Jul 2021)
Chronic Lymphocytic Leukemia (CLL) - diagnosis, prognosis and management with Ibrutinib
Переглядів 2483 роки тому
Chronic Lymphocytic Leukemia (CLL) - diagnosis, prognosis and management with Ibrutinib
Obinutuzumab - Dosage & Administration
Переглядів 1713 роки тому
Obinutuzumab - Dosage & Administration
Sath-Sath: Session2 (Jun2021)
Переглядів 943 роки тому
Sath-Sath: Session2 (Jun2021)
Sequencing of Therapy in mHSPC (metastatic Hormone Sensitive Prostate Cancer) cases
Переглядів 1403 роки тому
Sequencing of Therapy in mHSPC (metastatic Hormone Sensitive Prostate Cancer) cases
Latest updates in the EGFRm NSCLC Management in 2021
Переглядів 1033 роки тому
Latest updates in the EGFRm NSCLC Management in 2021
Treatment of Iron Deficiency Anemia in a Cancer Patient
Переглядів 3453 роки тому
Treatment of Iron Deficiency Anemia in a Cancer Patient
Sath-Sath: Session1 (May2021)
Переглядів 2403 роки тому
Sath-Sath: Session1 (May2021)
Role of Comprehensive Genomic Profiling in Cancer treatment
Переглядів 1463 роки тому
Role of Comprehensive Genomic Profiling in Cancer treatment
Management of NSCLC 2021
Переглядів 883 роки тому
Management of NSCLC 2021
The Profound Trial - Lynparza in HRRm mCRPC
Переглядів 2833 роки тому
The Profound Trial - Lynparza in HRRm mCRPC
Impact Of Nutrition In Cancer Patients
Переглядів 1923 роки тому
Impact Of Nutrition In Cancer Patients
Evolving Evidences in 1L RM SCCHN: Clinical Trials & Real World Evidences
Переглядів 613 роки тому
Evolving Evidences in 1L RM SCCHN: Clinical Trials & Real World Evidences